Abstract:Maple syrup urine disease (MSUD) is a rare autosomal recessive disorder that affects the degradation of branched chain amino acids (BCAAs). Only a few cases of MSUD have been documented in Mainland China, and prenatal diagnosis has not been performed so far. In this report, 8 patients (4 girls and 4 boys) with MSUD from 8 unrelated Chinese families were diagnosed at the age of 9 days to 1 year and 8 months. The diagnosis was confirmed by serum BCAAs and genetic analyses. Among the 8 patients, only one was detected by newborn screening. The remaining 7 patients were admitted because of neurological disorders and underwent selective screening. Significantly elevated BCAAs were observed in 7 patients. One patient was diagnosed by post-mortem study. 12 mutations were found in the BCKDHA, BCKDHB and DBT genes. 11 of these mutations were novel: c.178G > T, c.491T > C, c.740A > G, c.1214_1219dupCCAACC and IVS6 + 1delG in BCKDHA; c.482T > G, c.508C > T, c.767A > G, c.768C > G and IVS4, -2A > C in BCKDHB; and c.1A > G in DBT. Only one mutation, c.659C > T in the BCKDHA gene, had been previously reported. 7 patients were treated by dietary intervention and symptomatic therapy. 6 of them showed clinical improvement. The mother of one patient who died from MSUD underwent amniocentesis during her second pregnancy. The BCAAs level in her amniotic fluid was normal. Only one heterozygous mutation, IVS4, -2A > C in the BCKDHB gene, was detected in the cultured amniocytes. The results revealed that the fetus was not affected by MSUD. Normal development and the blood BCAAs profile confirmed the prenatal diagnosis after birth. Thus, we identified eleven novel mutations associated with MSUD in the Chinese population. Prenatal diagnosis of MSUD was successfully performed on one fetus by genetic analysis of the cultured amniocytes. (C) 2015 Elsevier Masson SAS. All rights reserved.

[Genetic Analysis of Two Chinese Families with Maple Syrup Urine Disease].

Identification of Eight Novel Mutations in 11 Chinese Patients with Maple Syrup Urine Disease

Eleven Novel Mutations of the BCKDHA, BCKDHB and DBT Genes Associated with Maple Syrup Urine Disease in the Chinese Population: Report on Eight Cases.

Genotypic and Phenotypic Spectrum of maple syrup urine disease in Zhejiang of China

Neonatal maple syrup urine disease in China: two novel mutations in the BCKDHB gene and literature review

Exploring molecular spectrum in thai patients with maple syrup urine disease: unveiling a common variant

Author Response for "genetic Spectrum and Clinical Profiles in a Southeast Chinese Cohort of Charcot‐Marie‐Tooth Disease"

Mutation Analysis of Ganglioside-Induced Differentiation Associated Protein-1 Gene in Chinese Charcot-Marie-Tooth Disease

Measurement of regional pulmonary blood flow with PET.

Expanding the genotypic and phenotypic spectrum of Egyptian children with maple syrup urine disease

Maple syrup urine disease diagnosis in Brazilian patients by massive parallel sequencing

Informing the future: 1. A review of nursing roles and responsibilities in community infection control.

[Genetic and clinical analysis of a child with Shwachman-Diamond syndrome due to compound heterozygous variants of SBDS gene]

Identification of Novel KMT2D Mutations in Two Chinese Children with Kabuki Syndrome: a Case Report and Systematic Literature Review

Novel KRIT1/CCM1 and MGC4607/CCM2 Gene Variants in Chinese Families with Cerebral Cavernous Malformations

Gck Mutations in Chinese Mody2 Patients: A Family Pedigree Report and Review of Chinese Literature

[Clinical and genetic analysis of two pedigrees affected with Carnitine-acylcarnitine translocase deficiency due to variant of SLC25A20 gene]

Molecular Scanning on MODY2 Genes in Early Onset Familial Type 2 Diabetes

An Early Diagnosis Leads to a Good Prognosis: a Patient with Maple Syrup Urine Disease--screened by Tandem Mass Spectrometry.

[Identification of a Novel Glucokinase-E339k Mutation in a Chinese Maturity Onset Diabetes of the Young 2 Pedigree].

Two novel GCK mutations in Chinese patients with maturity-onset diabetes of the young